Mobile apps for GlaxoSmithKline launch in U.S. and Russia


- Mobile apps for GlaxoSmithKline launch in U.S. and Russia

Priocept have completed the design and development of a new mobile application on the Android platform with initial launches in the United States and Russia.

The application acts a support tool for smokers wishing to cut-down or quit completely, and integrates with the web based support programme (also being developed by Priocept) currently being rolled out internationally.

The behavioural support programme offers advice and counselling for smokers trying to quit using GSK’s nicotine replacement therapy products. The system offers a free, personally tailored quit plan, complete with newsletters, award certificates and other motivational material.

U.S. users should visit www.committedquitters.com and Nicoderm CQ on the Android Market.

Roll-out of the application to the remaining GSK markets such as the U.K, Australia and Malaysia is scheduled for the coming months.